To the editor,
We read with great interest the article by Sevick et al1 that systematically reviewed and synthesized the literature on cost-effectiveness of endovascular therapy combined with standard care (EVT+SC) in acute ischemic large-vessel occlusion stroke. The authors conclude that EVT+SC is a cost-effective intervention when adopting willingness-to-pay thresholds of $50 000 per quality-adjusted life year compared with SC alone. Sevick et al also demonstrate the applicability of this conclusion across several different healthcare systems in Europe and North America. [...],
Department of Radiology

Kunz, W., Thierfelder, K., & Hunink, M. (2017). Letter by Kunz et al Regarding Article, "Systematic Review of the Cost and Cost-Effectiveness of Rapid Endovascular Therapy for Acute Ischemic Stroke". Stroke, 48(10). doi:10.1161/STROKEAHA.117.018907